TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹52 Cr | ₹37 Cr | ₹32 Cr | ₹38 Cr | ₹3.10 Cr |
What is the latest Net Current Assets ratio of TRIDENT LIFELINE ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹52 Cr |
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹32 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹3.10 Cr |
How is Net Current Assets of TRIDENT LIFELINE Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹52 Cr | 40.21 | |
| Mar2025 | ₹37 Cr | 16.07 | |
| Mar2024 | ₹32 Cr | -15.81 | |
| Mar2023 | ₹38 Cr | 1,116.93 | |
| Mar2022 | ₹3.10 Cr | - | |
Compare Net Current Assets of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹513.8 Cr | 3.5% | 13.3% | 42.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 3.5% |
13.3% |
42.8% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses